Literature DB >> 1721738

The immune response to intracerebral neural grafts.

D J Sloan1, M J Wood, H M Charlton.   

Abstract

Neural transplantation offers a potential therapeutic approach to a variety of neurological disorders, most notably those of a degenerative nature. However, the degree of immunological privilege (i.e. isolation from an immune response) in the brain, which is not absolute, may be a significant impediment to the survival of histoincompatible grafts. The nature of this privilege, together with the specific immune events leading to neural graft rejection, are discussed. As a consequence of this immune-mediated rejection, immunosuppression in some form might be necessary to guarantee long-term graft survival. Various strategies are being explored to suppress the immune response to neural grafts, not only for future use in clinical therapies, but also to bring intracerebral allo- and xenotransplantation to the attention of the general neurobiologist.

Entities:  

Mesh:

Year:  1991        PMID: 1721738     DOI: 10.1016/0166-2236(91)90159-r

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  13 in total

1.  A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease.

Authors:  R A Barker; E Ratcliffe; M McLaughlin; A Richards; S B Dunnett
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 2.  Stem cell myths.

Authors:  Tim Magnus; Ying Liu; Graham C Parker; Mahendra S Rao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

3.  Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination.

Authors:  A P Byrnes; R E MacLaren; H M Charlton
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

Review 4.  Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke.

Authors:  Ling Wei; Zheng Z Wei; Michael Qize Jiang; Osama Mohamad; Shan Ping Yu
Journal:  Prog Neurobiol       Date:  2017-03-18       Impact factor: 11.685

5.  The immunogenicity of intracerebral virus infection depends on anatomical site.

Authors:  P G Stevenson; S Hawke; D J Sloan; C R Bangham
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

Authors:  D Barba; J Hardin; M Sadelain; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Differential immune responses to fetal intracameral spinal cord and cortex cerebri grafts.

Authors:  M Shinoda; M Giacobini; R Schmidt-Kastner; K Trok; L Olson
Journal:  Exp Brain Res       Date:  1996-07       Impact factor: 1.972

8.  Schwann cells transplanted in the lateral ventricles prevent the functional and anatomical effects of monocular deprivation in the rat.

Authors:  T Pizzorusso; M Fagiolini; M Fabris; G Ferrari; L Maffei
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.

Authors:  K Geiger; E L Howes; N Sarvetnick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 10.  Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.

Authors:  Christopher Jackson; Jacob Ruzevick; Jillian Phallen; Zineb Belcaid; Michael Lim
Journal:  Clin Dev Immunol       Date:  2011-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.